Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2025-12-27 @ 5:28 PM
Study NCT ID:
NCT05346666
Status:
UNKNOWN
Last Update Posted:
2022-11-15
First Post:
2022-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Possible Immuno-Modulatory Effect of Tocilizumab in Patients With Refractory Status Epilepticus.
Sponsor:
Damanhour University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-20
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-24
First Submit QC Date:
None
Study First Post Date:
2022-04-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-10
Last Update Post Date:
2022-11-15
Last Update Post Date Type:
ACTUAL